购物车

全部删除
您的购物车当前为空

前往下单页继续购物

TWEAKR/TNFRSF12A Protein, Human, Recombinant (aa 28-80, hFc)

一键复制产品信息

产品编号 TMPY-02757U

TWEAKR/TNFRSF12A Protein, Human, Recombinant (aa 28-80, hFc) is expressed in HEK293 Cells. The accession number is Q9NP84-1.

TWEAKR/TNFRSF12A Protein, Human, Recombinant (aa 28-80, hFc)

一键复制产品信息

产品编号 TMPY-02757U

TWEAKR/TNFRSF12A Protein, Human, Recombinant (aa 28-80, hFc) is expressed in HEK293 Cells. The accession number is Q9NP84-1.

规格	价格	库存	数量

大包装 & 定制

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

资源下载

重组蛋白用户指南

产品信息

生物活性	Immobilized Human TNFRSF12A, hFc Tag at 0.5 μg/ml (100 μl/Well) on the plate. Dose response curve for Biotinylated Anti-TNFRSF12A Antibody, hFc Tag with the EC50 of 13.8 ng/ml determined by ELISA (QC Test). Human TNFSF12, hFc Tag immobilized on CM5 Chip can bind Human TNFRSF12A, hFc Tag with an affinity constant of 0.24 nM as determined in SPR assay (Biacore T200).
产品描述	TWEAKR/TNFRSF12A Protein, Human, Recombinant (aa 28-80, hFc) is expressed in HEK293 Cells. The accession number is Q9NP84-1.
种属	Human
表达系统	HEK293 Cells
标签	N-hFc
蛋白编号	Q9NP84-1
别名	TWEAKR,tumor necrosis factor receptor superfamily member 12A,FN14,CD266
蛋白构建	Glu28-Per80
蛋白纯度	> 95% as determined by Tris-Bis PAGE
分子量	32.9 kDa (Predicted); 38-45 kDa (Due to glycosylation)
内毒素	< 1.0 EU/μg of the protein as determined by the LAL method.
蛋白性状	Lyophilized powder
缓冲液	Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
存储	Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	Thyroid cancer (TC) is the most well-known endocrine neoplasia as well as a common malignant tumor in the head and neck.TNFRSF12A expression may be a potential useful prognostic molecular biomarker of bad survival in thyroid cancer, in addition, PPAR signaling pathway, insulin signaling pathway, mTOR signaling pathway may be the key pathway controlled by TNFRSF12A in thyroid cancer. Further experimental ought to be performed to demonstrate the biologic effect of TNFRSF12A.